CORONAVIRUS DISEASE (COVID-19) TREATMENT ALGORITHMS IN PATIENTS WITH QT INTERVAL PROLONGATION
Journal: Journal of the Grodno State Medical University (Vol.18, No. 2)Publication Date: 2020-05-02
Authors : Kalatsei L. V. Snezhitskiy V. A. Ardashev A. V.;
Page : 203-210
Keywords : coronavirus disease (COVID-19); hydroxychloroquine; QT interval; polymorphic ventricular tachycardia torsades de pointes;
Abstract
Since the frst cases of coronavirus disease (COVID-19) have been identifed, the search for effective drugs for its treatment has not stopped. The most promising in the treatment of COVID-19 are antimalarial, antiretroviral drugs and macrolide antibiotics. A common side effect for these groups of drugs is their ability to prolong the QT interval and induce paroxysms of polymorphic ventricular tachycardia torsades de pointes, especially in patients with genetic defects of ventricular myocardial repolarization. This article provides management algorithms of COVID-19 in patients with QT interval prolongation and risk of life-threatening ventricular arrhythmias, developed with the support of the EurAsian Arrhythmology Association (EURA-3).
Other Latest Articles
- 2019 EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH SUPRAVENTRICULAR TACHYCARDIA: WHAT’S NEW?
- HEMATURIA IN GENERAL PRACTITIONER PRACTICE
- ULTRASONIC DIAGNOSTICS IN SURGERY INGUINAL HERNIA
- DEMOGRAPHIC CHARACTERISTICS OF LIQUIDATORS OF CONSEQUENCES OF THE CHERNOBYL DISASTER AND PREDICTION OF THE INCIDENCE OF LEUKOSIS
- EFFICIENCY OF PHOTOMAGNETIC THERAPY IN EXPERIMENTAL ARTHRITIS
Last modified: 2020-05-11 17:08:54